Question:

7 Glaxco claims that its new sleeping pill Somatripan has a

Last updated: 3/10/2023

7 Glaxco claims that its new sleeping pill Somatripan has a

7 Glaxco claims that its new sleeping pill Somatripan has a mean time of entering the bloodstream of less than 10 min What should the null hypothesis be The alternate hypothesis Glaxco reports the results of the test have a p value of 004 The FDA requires a 005 level of significance for tests of new drugs Will the FDA approve Glaxco s drug